Axsome Therapeutics (AXSM) EPS (Diluted) Growth (1y) (2021 - 2026)
Axsome Therapeutics (AXSM) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 96.09% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 1,158.84% |
| 10 | Axsome Therapeutics | 12.26 Bn | 11.95 Bn | 176.48 Mn | -3.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.69% |
| Dec 31, 2025 | 63.19% |
| Sep 30, 2025 | 29.64% |
| Jun 30, 2025 | 41.82% |
| Mar 31, 2025 | 15.71% |
| Dec 31, 2024 | 28.00% |
| Sep 30, 2024 | -1.66% |
| Jun 30, 2024 | -8.41% |
| Mar 31, 2024 | -458.60% |
| Dec 31, 2023 | -44.15% |
| Sep 30, 2023 | -22.82% |
| Jun 30, 2023 | -45.10% |
| Mar 31, 2023 | 75.03% |
| Dec 31, 2022 | -61.35% |
| Sep 30, 2022 | 81.55% |
| Jun 30, 2022 | 81.76% |
| Mar 31, 2022 | -26.56% |
| Dec 31, 2021 | -15.26% |